Edgestream Partners, L.P.

Position in ZTS — Zoetis Inc.

CIK 1535061 Princeton, NJ

Position in ZTS

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$9,161,984

+$5,631,727 QoQ

Shares Held

77,506

+176.2% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $28,592,165 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (32.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	77,506	$9,161,984
2	NBIX	Neurocrine Biosciences Inc	50,587	$6,664,331
3	PBH	Prestige Consumer Healthcare Inc.	108,814	$6,449,405
4	VTRS	Viatris Inc	329,276	$4,448,518
5	ALKS	Alkermes plc.	52,826	$1,867,927

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,161,984	77,506	+176.2%	Shares	Sole	2026-05-18
2025-12-31	$3,530,257	28,058	-72.3%	Shares	Sole	2026-02-13
2025-09-30	$14,806,267	101,191	+810.8%	Shares	Sole	2025-11-12
2025-06-30	$1,732,604	11,110	-80.0%	Shares	Sole	2025-08-13
2025-03-31	$9,157,668	55,619	+466.4%	Shares	Sole	2025-05-02
2024-12-31	$1,599,972	9,820	-7.7%	Shares	Sole	2025-02-07
2024-09-30	$2,077,866	10,635	-16.4%	Shares	Sole	2024-11-14
2023-12-31	$2,511,138	12,723	+57.1%	Shares	Sole	2024-02-14
2023-06-30	$1,394,728	8,099	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.